Recombinant Escherichia coli flgM Protein ，His & Myc

FlgM is a key regulatory protein involved in the flagellar biosynthesis and control of motility in many bacteria, particularly in species such as *Salmonella* and *Escherichia coli*. This protein acts as an anti-sigma factor that interacts with the sigma factor σ28, inhibiting its function until the flagellum is fully assembled. The regulation of flagellar assembly is critical for bacterial motility, allowing these organisms to adapt to various environments and evade immune responses. Given the increasing interest in bacterial motility as a potential target for new antimicrobial therapies, research focused on FlgM has gained momentum. Studies have aimed to elucidate the molecular mechanisms through which FlgM exerts its regulatory effects, its interactions with other flagellar components, and the conditions that trigger its activity. Understanding FlgM's role in flagellar assembly not only provides insights into bacterial physiology but also opens avenues for the development of novel strategies to combat infections caused by motile pathogens. Furthermore, recombinant FlgM protein production has been leveraged for structural biology studies and high-throughput screening assays to identify compounds that can disrupt its function, potentially leading to new therapeutic agents that hinder bacterial motility and persistence.